Body fat, %
|
22.8 ± 7.51
|
29.7 ± 7.12
|
41.7 ± 6.73
|
< 0.001
|
SBP, mm Hg
|
102 ± 12.81
|
103 ± 10.61
|
108 ± 11.62
|
< 0.001
|
DBP, mm Hg
|
60 ± 9.81
|
61 ± 8.71
|
65 ± 11.62
|
< 0.001
|
Fasting plasma glucose, mmol/L
|
5.0 ± 0.401
|
5.1 ± 0.351,2
|
5.2 ± 0.502
|
0.005
|
Fasting plasma insulin, pmol/L
|
86.4 ± 28.51
|
116 ± 62.81
|
207 ± 1352
|
< 0.001
|
HOMA2-IR
|
1.6 ± 0.521
|
2.1 ± 1.11
|
3.5 ± 2.02
|
< 0.001
|
TG, mmol/L
|
0.76 ± 0.281
|
0.90 ± 0.461
|
1.1 ± 0.612
|
< 0.001
|
HDL-C, mmol/L
|
1.5 ± 0.261
|
1.3 ± 0.322
|
1.1 ± 0.283
|
< 0.001
|
TG/HDL-C ratio
|
0.55 ± 0.281
|
0.7 ± 0.431
|
1.1 ± 0.722
|
< 0.001
|
|
CDC
| |
|
(n = 101)
|
(n = 51)
|
(n = 136)
| |
Body fat, %
|
23.2 ± 7.41
|
28.5 ± 7.12
|
41.0 ± 7.03
|
< 0.001
|
SBP, mm Hg
|
102 ± 12.61
|
102 ± 10.91
|
108 ± 11.52
|
< 0.001
|
DBP, mm Hg
|
60 ± 9.81
|
60 ± 8.41
|
65 ± 11.32
|
< 0.001
|
Fasting plasma glucose, mmol/L
|
5.0 ± 0.391
|
5.1 ± 0.351, 2
|
5.2 ± 0.502
|
0.002
|
Fasting plasma insulin, pmol/L
|
86.3 ± 28.51
|
114 ± 67.01
|
201 ± 1312
|
< 0.001
|
HOMA2-IR
|
1.6 ± 0.521
|
2.1 ± 1.21
|
3.5 ± 1.92
|
< 0.001
|
TG, mmol/L
|
0.77 ± 0.281
|
0.87 ± 0.481
|
1.1 ± 0.602
|
< 0.001
|
HDL-C, mmol/L
|
1.5 ± 0.261
|
1.3 ± 0.341
|
1.1 ± 0.292
|
< 0.001
|
TG/HDL-C ratio
|
0.56 ± 0.271
|
0.70 ± 0.441
|
1.1 ± 0.712
|
< 0.001
|
|
WHO
| |
|
(n = 91)
|
(n = 55)
|
(n = 142)
| |
Body fat, %
|
22.8 ± 7.51
|
28.0 ± 6.92
|
40.6 ± 7.23
|
< 0.001
|
SBP, mm Hg
|
103 ± 13.01
|
102 ± 10.91
|
107 ± 11.42
|
0.001
|
DBP, mm Hg
|
59 ± 9.91
|
60 ± 7.91
|
65 ± 11.42
|
< 0.001
|
Fasting plasma glucose, mmol/L
|
5.0 ± 0.401
|
5.0 ± 0.351,2
|
5.2 ± 0.492
|
0.008
|
Fasting plasma insulin, pmol/L
|
85.8 ± 28.01
|
109 ± 62.91
|
197 ± 1302
|
< 0.001
|
HOMA2-IR
|
1.6 ± 0.511
|
2.0 ± 1.11
|
3.4 ± 1.92
|
< 0.001
|
TG, mmol/L
|
0.77 ± 0.291
|
0.86 ± 0.461
|
1.1 ± 0.592
|
< 0.001
|
HDL-C, mmol/L
|
1.5 ± 0.271
|
1.3 ± 0.321
|
1.2 ± 0.302
|
< 0.001
|
TG/HDL-C ratio
|
0.55 ± 0.281
|
0.70 ± 0.431
|
1.1 ± 0.702
|
< 0.001
|